Lupin Limited — Febuxostat Exporter Profile
Indian Pharmaceutical Exporter · #4 for Febuxostat · $1.5M export value · DGFT Verified
Lupin Limited is the #4 Indian exporter of Febuxostat with $1.5M in export value and 30 verified shipments. Lupin Limited holds a 3.1% market share in Febuxostat exports across 2 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Febuxostat Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Febuxostat?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $1.4M | 28 | 96.3% |
| MYANMAR | $53.4K | 2 | 3.7% |
Lupin Limited exports Febuxostat to 2 countries. The largest destination is PHILIPPINES accounting for 96.3% of Lupin Limited's Febuxostat shipments. These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Febuxostat from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MULTICARE PHARMACEUTICALS | PHILIPPINES | $1.0M | 20 |
| MULTICARE PHARMACEUTICALS PHILIPPIN | PHILIPPINES | $350.0K | 7 |
| J D S CO LTD NO 9 YAWMINGYI | MYANMAR | $53.4K | 2 |
| MULTICARE PHARMACEUTICALS 7F UNITS | PHILIPPINES | $50.0K | 1 |
Lupin Limited supplies Febuxostat to 4 buyers globally. The largest buyer is MULTICARE PHARMACEUTICALS (PHILIPPINES), followed by MULTICARE PHARMACEUTICALS PHILIPPIN (PHILIPPINES) and J D S CO LTD NO 9 YAWMINGYI (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Febuxostat Export Value and How Much Does Lupin Limited Contribute?
India exported $24.2M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. Lupin Limited contributes $1.5M to this total, accounting for 3.1% of India's Febuxostat exports. Lupin Limited ships Febuxostat to 2 countries through 4 buyers.
What Is the Average Shipment Value for Lupin Limited's Febuxostat Exports?
Lupin Limited's average Febuxostat shipment value is $50.0K per consignment, based on 30 shipments totaling $1.5M. The largest destination is PHILIPPINES (96.3% of Lupin Limited's Febuxostat exports).
How Does Lupin Limited Compare to Other Indian Febuxostat Exporters?
Lupin Limited ranks #4 among 182 Indian Febuxostat exporters with a 3.1% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($6.0M), AJANTA PHARMA LIMITED ($4.5M), ALEMBIC PHARMACEUTICALS LIMITED ($2.8M). Lupin Limited processed 30 shipments to 2 destination countries.
What Febuxostat Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG | $200.0K | 4 |
| FURIC 40 10X10 FEBUXOSTAT TABLETS 40MG O | $150.0K | 3 |
| FURIC 40-10X10T(EXPORT)(FEBUXOSTAT TABS40MG)BT#JA00915 TO JA00924,MFG#04.2024,EXP#03.2026(OTHERS-MEDICINE PUT UP FOR RE | $150.0K | 3 |
| FURIC 80 10X10 FEBUXOSTAT TABLETS 80MG B | $100.0K | 2 |
| Furic 80 - 10 x 10T (Export) FebuxostatTablets 80 mg Others-Medicine Put Up ForRetail Sale | $100.0K | 2 |
| FURIC 80-10X10 FEBUXOSTAT TABLETS 80MG O | $50.0K | 1 |
| FURIC 40-10X10 FEBUXOSTAT TABLETS 40MG O | $50.0K | 1 |
| FURIC 80 10X10T FEBUXOSTAT TABLETS 80MG | $50.0K | 1 |
| FURIC 40-10 X10T (EXPORT)FEBUXOSTAT TABL | $50.0K | 1 |
| FURIC 40 10X10 FEBUXOSTAT TABLETS 40MG | $50.0K | 1 |
Lupin Limited exports 21 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FURIC 40 10X10T FEBUXOSTAT TABLETS 40MG with 4 shipments worth $200.0K.
How Does Lupin Limited Compare to Nearest Febuxostat Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MACLEODS PHARMACEUTICALS LTD | $2.1M | 68 | 12 | $31.5K |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $2.0M | 52 | 7 | $38.7K |
| 4 | LUPIN LIMITED ★ | $1.5M | 30 | 2 | $50.0K |
| 7 | WATSON PHARMA PRIVATE LIMITED | $1.1M | 21 | 2 | $50.0K |
| 8 | INDOCO REMEDIES LIMITED | $976.4K | 23 | 3 | $42.5K |
Lupin Limited ranks #4 among 182 Indian Febuxostat exporters. Average shipment value of $50.0K compared to the market average of $132.8K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Febuxostat Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 639 | 18.3% |
| SAHAR AIR | 615 | 17.6% |
| DELHI AIR | 387 | 11.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 351 | 10.0% |
| NHAVA SHEVA SEA (INNSA1) | 145 | 4.1% |
| HYDERABAD ICD (INSNF6) | 98 | 2.8% |
| HYDERABAD AIR | 96 | 2.7% |
| Bombay Air | 84 | 2.4% |
Geopolitical & Trade Policy Impact on Lupin Limited's Febuxostat Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Febuxostat, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching Lupin Limited exporting Febuxostat, covering 21 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Febuxostat exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Febuxostat Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current shipment-level data, contact TransData Nexus.